The anti-inflammatory feature of glucagon-like peptide-1 and its based diabetes drugs – Therapeutic potential exploration in lung injury
Short title : GLP-1 based drugs in anti-inflammation
Juan Pang1,2, Jia Nuo Feng2,3, Wenhua Ling1, and Tianru Jin2,3,4*
1 Department of Nutrition, School of Public Health, Sun Yat-sen University, Guangzhou, PR China.
2 Division of Advanced Diagnostics, Toronto General Hospital Research Institute, University Health Network, Toronto, Canada.
3 Department of Physiology, Faculty of Medicine, University of Toronto, Toronto, Canada.
4 Banting and Best Diabetes Centre, Faculty of Medicine, University of Toronto, Toronto, Canada.
* Correspondent author